Clinical Guides
Chickenpox (Varicella)
A clinically focused guide to recognising and containing varicella in India, with explicit pathways for pregnancy, neonates and immunocompromise, time-sensitive prevention and treatment, and clear limits where specialist or local public-health advice is required.
MedNext Academy | 14 min read
Chickenpox (Varicella)
A clinically focused guide to recognising and containing varicella in India, with explicit pathways for pregnancy, neonates and immunocompromise, time-sensitive prevention and treatment, and clear limits where specialist or local public-health advice is required.
Summary
Chickenpox is primary infection with varicella-zoster virus, a human herpesvirus that later remains latent in sensory ganglia and may reactivate as herpes zoster. The usual illness combines fever or malaise with an itchy, centripetal eruption in successive crops: macules become papules, clear vesicles and then crusts, so lesions at different stages coexist. Vaccinated people can have fewer, mainly maculopapular lesions, but breakthrough disease remains transmissible. The diagnosis is often clinical in a typical child; atypical, severe, pregnancy-associated, neonatal, immunocompromised or outbreak cases deserve laboratory confirmation and specialist input.
Transmission occurs through airborne particles and respiratory secretions and by direct contact with vesicular fluid. A person is infectious from one to two days before rash onset until every lesion has crusted. If lesions do not crust, as can occur after vaccination, use absence of new lesions for 24 hours as the practical endpoint. Keep the patient away from susceptible pregnant people, newborns and immunocompromised people, and apply airborne plus contact precautions in healthcare.
Most healthy children need symptom relief, hydration, skin care and safety-netting rather than antivirals. Antiviral benefit is time-sensitive and patient-specific; oral treatment is considered for selected higher-risk patients when it can begin early, while severe or disseminated disease generally needs hospital care and intravenous therapy. Post-exposure vaccination or varicella-zoster immune globulin may be appropriate depending on immunity, contraindications, exposure and timing. Live vaccine is contraindicated during pregnancy. This draft is educational and remains quarantined following MedNext Clinical Team review.
How Common Is It?
Varicella occurs worldwide, but age at infection, seasonality, vaccination practice and surveillance completeness vary. In settings without routine childhood vaccination, most people acquire infection during childhood, although some remain susceptible into adolescence or adulthood. Disease is so transmissible that CDC cites household studies in which about 90% of susceptible close contacts became infected. That estimate describes intense household exposure, not a universal attack rate for every brief contact. Incubation is usually 14 to 16 days and can range from 10 to 21 days.
India does not have a single reliable, current national case count because uncomplicated chickenpox is frequently diagnosed outside laboratory surveillance and reporting differs by jurisdiction. Outbreaks occur in homes, hostels, schools, residential institutions and healthcare settings. The national Universal Immunisation Programme schedule listed in the Ministry of Health routine-immunisation manual includes BCG, hepatitis B, polio, pentavalent, rotavirus, pneumococcal, measles-rubella and selected-area Japanese encephalitis vaccines, but it does not list varicella vaccine. That observation must not be misread as a recommendation against private-sector vaccination or as proof that no state or institution offers it.
Most childhood disease is self-limited, yet burden includes school absence, caregiver work loss, secondary bacterial infection and exposure of vulnerable contacts before the index rash is recognised. Adults have a greater risk of pneumonia and severe illness than young immunocompetent children. Pregnancy, infancy and impaired cellular immunity concentrate serious outcomes. Population burden therefore cannot be assessed from rash counts alone; a mild index case may create a high-consequence exposure for a pregnant healthcare worker, neonate or person receiving chemotherapy.
Risk Factors
The essential risk factor for infection is absence of reliable immunity combined with meaningful exposure to varicella or uncovered herpes zoster lesions. Evidence of immunity depends on documented age-appropriate vaccination, laboratory evidence, or a clinician-verified history under the policy used by the receiving service. Self-recalled childhood rash can be uncertain, especially where several febrile exanthems circulate. Household residence, dormitory living, school attendance, inpatient contact and healthcare work increase opportunities for close exposure. A person with localised zoster can transmit VZV to a susceptible contact, who develops chickenpox rather than shingles.
Risk of severe disease is distinct from risk of acquiring infection. Adolescents and adults, pregnant people without immunity, newborns around maternal peripartum varicella, premature hospitalized infants and people with impaired cellular immunity warrant particular attention. Immunocompromise includes leukaemia or lymphoma, transplantation, advanced immune deficiency and treatment with chemotherapy or substantial systemic immunosuppression. Do not infer safety from a small early rash: immunocompromised patients can develop prolonged crops, haemorrhagic lesions and visceral dissemination affecting lung, liver, brain or coagulation.
Maternal rash from five days before through two days after delivery places the newborn in a recognised high-risk window because passive antibody transfer may be insufficient. Maternal infection in early pregnancy carries a small risk of congenital varicella syndrome, while maternal pneumonia threatens the pregnant patient at any gestation. Exposure risk assessment should document timing, closeness, lesion coverage, ventilation, immune status and host vulnerability. Long-term salicylate use, chronic skin or pulmonary disease and corticosteroid exposure influence treatment discussions. Vaccine eligibility must be checked separately because pregnancy and significant immunosuppression can contraindicate live varicella vaccine.
Diagnosis
History
Establish the exact day of fever, prodrome and first skin lesion; exposure to chickenpox or shingles 10 to 21 days earlier; prior disease, vaccination or laboratory evidence of immunity; and whether new lesions are still appearing. Ask about cough, dyspnoea, severe headache, confusion, ataxia, poor intake, reduced urine, persistent vomiting, focal pain and rapidly spreading erythema. Record pregnancy or postpartum status, gestation, neonatal age, prematurity, immune disease, cancer treatment, transplantation and all immunosuppressive or salicylate medicines. Identify susceptible high-risk contacts and attendance at school, hostel, work or healthcare while infectious.
Examination
Assess temperature, respiratory rate, oxygen saturation, hydration, mental state and haemodynamic stability before counting lesions. Typical varicella is a pruritic, mainly truncal and facial eruption with lesions in several stages; scalp and mucosal lesions may occur. Examine for cellulitis, disproportionate pain, purulence, necrosis, haemorrhagic lesions, pneumonia, neurological signs, hepatitis or bleeding. In infants examine feeding, perfusion and work of breathing. Avoid exposing a shared waiting room: mask and separate the patient promptly, using airborne and contact precautions in clinical facilities.
Investigations
Typical uncomplicated childhood disease often needs no test. Polymerase chain reaction from vesicle fluid, a fresh lesion-base specimen or scab is the preferred confirmation when diagnosis matters; technique and laboratory instructions determine specimen acceptability. Testing is valuable for atypical or breakthrough rash, severe disease, pregnancy, immunocompromise, neonates, healthcare exposures and clusters requiring public-health decisions. Serology may help establish susceptibility before an exposure plan, but commercial assays can miss vaccine-induced immunity and IgM has important specificity and timing limitations. Order blood counts, liver tests, imaging, blood gases or cerebrospinal evaluation only when clinical complications indicate them, and involve specialists before invasive testing in an unstable patient.
Differential Diagnosis
Hand-foot-and-mouth disease favours oral ulcers with acral, buttock or perioral lesions; eczema herpeticum produces painful monomorphic vesicles or punched-out erosions on eczematous skin and can become an emergency. Disseminated herpes simplex, impetigo, bullous impetigo, insect bites, scabies, papular urticaria and drug eruptions can imitate parts of the picture. Mpox often has deep-seated lesions, lymphadenopathy and lesions at a similar stage within a body region, but presentation and epidemiology vary; suspected cases require the current public-health pathway rather than visual diagnosis alone.
Measles usually begins with cough, coryza and conjunctivitis followed by a confluent maculopapular rash, not crops of superficial vesicles. Disseminated zoster follows reactivation and is more likely in an immunocompromised host; localised zoster is painful and dermatomal. Dermatitis herpetiformis, pityriasis lichenoides and vesiculobullous autoimmune disease become relevant when evolution is prolonged or morphology is atypical. A purpuric or haemorrhagic eruption with systemic illness should not be labelled severe chickenpox without excluding sepsis, vasculitis and coagulation disorders.
The differential changes with age and context. In a neonate, congenital infections, bacterial sepsis with pustules, neonatal herpes and inherited blistering disorders demand urgent evaluation. In pregnancy, the consequences of a false reassurance are substantial, so confirm atypical disease promptly. In a vaccinated child, a mild maculopapular breakthrough eruption may be difficult to recognise clinically and PCR is useful. Secondary bacterial infection can coexist with genuine varicella; new fever, expanding erythema or disproportionate pain after initial improvement is a complication, not automatically a competing diagnosis.
Management
Immediately separate a suspected infectious patient from susceptible high-risk people. At home, avoid school, hostel, work and nonessential public contact until all lesions are crusted; where lesions never crust, wait until no new lesions have appeared for 24 hours. Keep nails short, use gentle bathing, discourage scratching, maintain fluids and use age-appropriate fever or itch relief according to local formulary advice. Aspirin is avoided in children with varicella because of the association with Reye syndrome. Avoid casual ibuprofen or other non-steroidal anti-inflammatory use in a child with varicella, particularly when skin infection is possible; seek clinician advice.
Otherwise healthy children with typical uncomplicated disease usually do not need acyclovir. For selected people at increased risk of moderate-to-severe illness, oral acyclovir or valaciclovir may be considered after clinical assessment; maximum benefit requires initiation within the first 24 hours after rash begins. Starting late in an uncomplicated recovering child has limited expected value. Severe, disseminated or visceral disease and varicella in a significantly immunocompromised patient require urgent hospital and specialist assessment, usually including intravenous acyclovir, renal assessment and monitored supportive care. Pregnancy-associated disease merits obstetric and infectious-disease coordination; pneumonia or other complication requires urgent intravenous treatment.
After exposure, establish immunity, exposure significance, host risk and time since contact. An eligible susceptible person without contraindication may benefit from live varicella vaccination as soon as possible, ideally within three to five days, but policy and product schedule must follow an authorised immunisation service. Susceptible high-risk people who cannot receive vaccine may need varicella-zoster immune globulin as soon as possible; CDC allows its US product within ten days, but Indian availability and product instructions vary. Neither prophylaxis guarantees prevention, so arrange surveillance and rapid reassessment if symptoms develop.
Prescribing Information
Antiviral prescribing is not a one-size-fits-all rash prescription. Verify age, weight, pregnancy, renal function, hydration, immune status, rash-onset time, disease severity and ability to absorb oral medicine. Oral acyclovir has limited bioavailability and frequent dosing; valaciclovir offers better oral exposure but paediatric indications and formulations differ. Intravenous acyclovir is reserved for severe or high-risk disease under monitored care because dose, infusion, hydration and renal adjustment matter. Nephrotoxicity and neurotoxicity become more likely with dehydration, renal impairment or dosing error. Acyclovir-resistant VZV is unusual and mainly encountered in immunocompromised patients; suspected resistance needs specialist virology and infectious-disease input rather than empiric escalation.
Do not prescribe aspirin to a child with varicella. Fever relief should use a locally appropriate alternative at a verified dose; medicine is supportive, not a way to conceal deterioration. Sedating antihistamines, topical preparations and antibiotics require individual assessment. Antibiotics do not treat VZV and should be reserved for a diagnosed or strongly suspected bacterial complication. Avoid topical antibiotics over hundreds of lesions, unregulated herbal applications and skin-breaking remedies. Check every preparation for duplicated active ingredients.
Varicella vaccine is live attenuated. It is not given during pregnancy and is generally contraindicated in substantial immunosuppression, although carefully defined immune conditions may have specialist pathways. Verify the product insert, cold chain, minimum intervals and national or professional guidance. Varicella-zoster immune globulin is passive prophylaxis for a narrow group, not treatment for established rash. Availability, formulation and timing differ across countries, so a US brand recommendation cannot be copied into an Indian prescription. Document exposure time, rationale, consent, product, batch, route and follow-up, and never delay urgent care while sourcing prophylaxis.
When to Refer
Arrange same-day clinical review for a pregnant person with suspected chickenpox or a significant exposure without reliable immunity. Do not send them unannounced into a crowded antenatal clinic; telephone the receiving obstetric or infectious-disease service so isolation and exposure assessment can be prepared. The same urgency applies to a neonate exposed around maternal delivery, a hospitalized premature infant, a person receiving chemotherapy or major immunosuppression, or any immunocompromised patient with a new compatible rash. Advice may be time-sensitive even before illness appears because immune globulin and vaccination have exposure windows.
Refer urgently to hospital for breathlessness, hypoxaemia, persistent chest pain, confusion, severe headache, ataxia, seizures, haemodynamic compromise, dehydration that prevents oral intake, haemorrhagic lesions, jaundice, bleeding, extensive mucosal disease or rapidly progressive rash. Secondary bacterial infection needs prompt assessment when pain, swelling, warmth, pus, rapidly advancing erythema, recurrent fever or systemic toxicity develops. Adult disease deserves a lower threshold for review because pneumonia can progress quickly. Ocular involvement or reduced vision requires ophthalmic assessment.
Routine primary-care follow-up is reasonable for an immunocompetent child who is drinking, breathing comfortably, alert and improving, provided caregivers understand isolation and red flags. Liaise with infection control for healthcare exposures and with local public-health teams when institutional outbreaks, vulnerable cohorts or reporting rules warrant it. School certificates should reflect infectious criteria rather than an arbitrary fixed number of days. Verify the local referral pathway, transport and capacity; do not assume that every district stocks VZV PCR, immune globulin or intravenous antiviral therapy.
Red Flags
Respiratory red flags are increasing work of breathing, tachypnoea, cyanosis, falling oxygen saturation, haemoptysis or chest pain, particularly in adults, pregnancy and immunocompromise. Neurological danger signs include altered behaviour, drowsiness, severe headache, neck stiffness, repeated vomiting, seizures, weakness or ataxia. Circulatory compromise, poor urine output, inability to drink and persistent high fever require urgent reassessment. Visceral dissemination may occur with relatively atypical skin findings in an immunocompromised patient, so a modest lesion count does not provide reassurance.
Skin warning signs include rapidly spreading erythema, disproportionate pain, swelling, pus, blackening, crepitus, haemorrhagic lesions or fever returning after initial improvement. These can indicate invasive group A streptococcal or staphylococcal infection, necrotising soft-tissue infection, thrombocytopenia or disseminated disease. Eye pain, photophobia or visual change is also urgent. A clinician should reconsider the diagnosis if lesions are monomorphic, deeply embedded, predominantly acral, unusually painful or associated with marked lymphadenopathy.
Host-context red flags are pregnancy, rash from five days before to two days after delivery, neonatal symptoms, prematurity with exposure, absent immunity under significant immunosuppression and recent transplantation or chemotherapy. A susceptible high-risk contact should not wait for rash before seeking advice. In healthcare, an unisolated suspected case is an infection-control event because exposure begins before rash recognition. If a child becomes difficult to wake, breathless, unable to drink or much sicker, emergency care takes priority over completing a photograph, online consultation or laboratory form.
Indian Clinical Context
Chickenpox care in India spans home care, primary facilities, paediatric and adult hospitals, obstetric services, private vaccination clinics and variable laboratory networks. The Universal Immunisation Programme schedule in the current Ministry of Health manual does not list varicella vaccine. Therefore clinicians must ask specifically about privately administered doses and inspect records rather than assuming vaccination or nonvaccination from age. The schedule's omission also means that US two-dose programme outcomes cannot be used to infer national Indian incidence. Local outbreaks and seroprevalence differ by age, climate, housing and access.
At a busy clinic, infection control is a major intervention: screen fever-with-rash at entry, avoid shared waiting, provide a mask when tolerated, place the patient in a closed room if negative-pressure space is unavailable, and use immune staff where possible. Airborne and contact precautions should continue until lesions are dry and crusted. Households need counselling in an understood language about the pre-rash infectious period, keeping away from pregnant, neonatal and immunocompromised contacts, and the need to call before attending a facility.
VZV PCR, specialist consultation, varicella vaccine and varicella-zoster immune globulin may not be equally accessible. Record what is actually available, escalate early when prophylaxis is time-limited, and avoid promising a product. Indian Academy of Pediatrics or institutional vaccination policy may guide individual immunisation outside UIP, but this draft does not replace it. Public-health reporting requirements can be state- or outbreak-specific. When international guidance is used, state its jurisdiction and adapt it through Indian formulary, product licensing, cold-chain, referral and infection-control systems.
NMC Competency Mapping
This guide supports competency-based learning across microbiology, paediatrics, dermatology, pharmacology, obstetrics and community medicine. The microbiology learner should explain primary VZV infection, latency, transmission, specimen selection and the role and limitations of PCR and serology. The clinical learner should recognise a polymorphic vesicular exanthem, distinguish uncomplicated disease from bacterial, pulmonary, neurological and disseminated complications, and select urgency according to host risk. The pharmacology learner should explain why antiviral timing, renal adjustment and route matter and why routine antibiotics or aspirin are inappropriate.
For paediatrics and dermatology, the observable skills are structured fever-and-rash history, morphology and distribution description, hydration and systemic assessment, differential diagnosis, caregiver counselling and safety-netting. Obstetric integration requires immediate exposure assessment, recognition of maternal pneumonia risk, congenital-varicella counselling without exaggerated certainty, and a coordinated peripartum neonatal pathway. Community-medicine integration includes isolation, contact identification, outbreak control, vaccine-schedule interpretation and communication of uncertainty. These activities should be assessed by cases, supervised examination and counselling stations rather than recall alone.
The 2024 NMC curriculum is the source of the competency framework, but exact code allocation can change between curriculum versions and institutional maps. Faculty should bind this guide to the current official local ledger rather than reuse older internet code lists. Completion of this page does not certify examination of a contagious child, specimen collection, vaccine administration or antiviral prescribing. Learners should demonstrate these skills under supervision, document jurisdiction and escalate vulnerable exposures rather than treating the guide as independent clinical authority.
Key Exam Pearls for NEET PG
Varicella produces successive crops of pruritic lesions, so macules, papules, vesicles and crusts coexist; the distribution is usually centripetal. Primary VZV infection is chickenpox, while reactivation from sensory ganglia is herpes zoster. Incubation is 10 to 21 days. Infectiousness begins one to two days before rash and lasts until all lesions crust; breakthrough lesions that do not crust remain infectious until no new lesion has appeared for 24 hours. In healthcare, use airborne and contact precautions. The preferred confirmatory test is VZV PCR from an appropriate lesion specimen.
Remember the severity groups: susceptible pregnancy, peripartum maternal rash, newborn or premature infant, adolescent or adult disease, and impaired cellular immunity. Common complications include bacterial skin and soft-tissue infection in children and pneumonia in adults; encephalitis, cerebellar ataxia, hepatitis, thrombocytopenia and dissemination are high-yield serious complications. Maternal rash from five days before to two days after delivery creates a classic neonatal risk window. Live varicella vaccine is contraindicated in pregnancy and substantial immunosuppression.
Routine acyclovir is not recommended for an otherwise healthy child with uncomplicated varicella. When oral antiviral treatment is chosen for a higher-risk patient, greatest benefit is expected if begun within 24 hours of rash onset. Severe or disseminated disease and significant immunocompromise generally require intravenous therapy and specialist care. Post-exposure live vaccine works best when given promptly, within three to five days, for eligible susceptible contacts. Susceptible high-risk contacts unable to receive vaccine may require VZ immune globulin. Neither intervention replaces observation and safety-netting.
Frequently Asked Questions
When can a child with chickenpox return to school or childcare?
Return is appropriate only after the infectious period has ended: every lesion should be dry and crusted. If a vaccinated child has lesions that do not crust, there should have been no new lesion for at least 24 hours. A fixed five- or seven-day rule is unsafe if fresh lesions are still appearing.
What should a pregnant person do after exposure to chickenpox?
They should telephone their obstetric or infectious-disease service promptly and avoid entering a crowded clinic without warning. The team will establish reliable immunity, confirm whether exposure was significant and consider time-sensitive prophylaxis. Live varicella vaccine is contraindicated during pregnancy; immune-globulin access and policy vary locally.
Does every child with chickenpox need oral acyclovir?
No. Otherwise healthy children with typical uncomplicated varicella usually need supportive care and careful safety-netting. Oral antiviral treatment is reserved for selected higher-risk patients after clinical assessment and has greatest expected benefit when started within 24 hours after the rash begins. Severe disease needs urgent hospital review.
Can vaccination or immune globulin completely prevent illness after exposure?
Neither offers a guarantee. Prompt vaccination can prevent or reduce disease in an eligible susceptible contact, while varicella-zoster immune globulin may prevent or attenuate illness in selected high-risk people who cannot receive vaccine. Timing, actual exposure, immune status, product availability and local protocols all determine the plan, and symptom surveillance remains necessary.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic